MAP3K2
Mitogen-activated protein kinase kinase kinase 2
Also known as: M3K2_HUMAN, MEKK2, MEKK2B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2U5
- Gene
- MAP3K2
- Ensembl
- ENSG00000169967
- Chromosome
- 2
- Canonical length
- 619 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of serine/threonine protein kinase family. This kinase preferentially activates other kinases involved in the MAP kinase signaling pathway. This kinase has been shown to directly phosphorylate and activate Ikappa B kinases, and thus plays a role in NF-kappa B signaling pathway. This kinase has also been found to bind and activate protein kinase C-related kinase 2, which suggests its involvement in a regulated signaling process. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
619 residues, UniProt reviewed canonical sequence.
>Q9Y2U5|MAP3K2
1 MDDQQALNSI MQDLAVLHKA SRPALSLQET RKAKSSSPKK QNDVRVKFEH RGEKRILQFP
61 RPVKLEDLRS KAKIAFGQSM DLHYTNNELV IPLTTQDDLD KAVELLDRSI HMKSLKILLV
121 INGSTQATNL EPLPSLEDLD NTVFGAERKK RLSIIGPTSR DRSSPPPGYI PDELHQVARN
181 GSFTSINSEG EFIPESMDQM LDPLSLSSPE NSGSGSCPSL DSPLDGESYP KSRMPRAQSY
241 PDNHQEFSDY DNPIFEKFGK GGTYPRRYHV SYHHQEYNDG RKTFPRARRT QGTSLRSPVS
301 FSPTDHSLST SSGSSIFTPE YDDSRIRRRG SDIDNPTLTV MDISPPSRSP RAPTNWRLGK
361 LLGQGAFGRV YLCYDVDTGR ELAVKQVQFD PDSPETSKEV NALECEIQLL KNLLHERIVQ
421 YYGCLRDPQE KTLSIFMEYM PGGSIKDQLK AYGALTENVT RKYTRQILEG VHYLHSNMIV
481 HRDIKGANIL RDSTGNVKLG DFGASKRLQT ICLSGTGMKS VTGTPYWMSP EVISGEGYGR
541 KADIWSVACT VVEMLTEKPP WAEFEAMAAI FKIATQPTNP KLPPHVSDYT RDFLKRIFVE
601 AKLRPSADEL LRHMFVHYHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAP3K2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 32 nTPM
- liver: 19 nTPM
- thyroid gland: 16 nTPM
- retina: 14 nTPM
- tonsil: 13 nTPM
- parathyroid gland: 13 nTPM
Single-cell type
- neutrophils: 2,588 nCPM
- neutrophil progenitors: 646 nCPM
- monocytes: 557 nCPM
- monocyte progenitors: 520 nCPM
- pdcs: 430 nCPM
- myonuclei: 375 nCPM
Immune cell
- neutrophil: 8.3 nTPM
- plasmacytoid DC: 3.6 nTPM
- basophil: 2.8 nTPM
- memory B-cell: 2.2 nTPM
- classical monocyte: 2 nTPM
- naive B-cell: 1.9 nTPM
Brain region
- white matter: 36 nTPM
- medulla oblongata: 29 nTPM
- hypothalamus: 28 nTPM
- cerebral cortex: 27 nTPM
- spinal cord: 26 nTPM
- basal ganglia: 26 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAP3K2.
Disease | ImmuneIEDB
Conditions an epitope on MAP3K2 was assayed in.
- gastrointestinal system cancer T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.09
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.31
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- MAP kinase kinase kinase activity
- metal ion binding
- protein kinase activity
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAP3K2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAP3K2 as an antibody target. Whether an autoantibody or antibody against MAP3K2 could matter depends on whether native MAP3K2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAP3K2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAP3K2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...